Antibody-drug Conjugate BMS-986517

**Semantic type:** Pharmacologic Substance

**Definition:** An antibody-drug conjugate (ADC) composed of an as of yet undisclosed monoclonal antibody directed against a tumor-associated antigen (TAA) linked to an as of yet undisclosed cytotoxic agent, with potential antineoplastic activity. Upon administration, the monoclonal antibody moiety of ADC BMS-986517 targets and binds to the TAA expressed on tumor cells. Upon binding and internalization, the cytotoxic agent is released and kills the TAA-expressing cancer cells, through an as of yet unknown mechanism of action.

**Synonyms:** - ADC BMS-986517 - BMS 986517 - BMS-986517 - BMS986517